Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/25/2018 |
| Start Date: | August 2006 |
| End Date: | September 2006 |
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Buprenorphine HCl (Sublingual) 8 mg Tablets With a Naltrexone Block Under Fasting Conditions
The objective of this study was to prove the bioequivalence of Buprenorphine HCl 8 mg tablet
under fasted conditions.
under fasted conditions.
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening.
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs. History of allergic or adverse response to
buprenorphine hydrochloride or any comparable or similar product.
We found this trial at
1
site
Click here to add this to my saved trials
